Lv31
260 积分 2023-11-14 加入
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study
2个月前
已完结
From the archives of MD Anderson Cancer Center: Monomorphic epitheliotropic intestinal T-cell lymphoma: A case with an unusual immunophenotype and discussion of differential diagnosis
2个月前
已完结
High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial
5个月前
已完结
Paraprotein-Mediated Glomerular Diseases
5个月前
已关闭
Kidney and liver involvement in monoclonal light chain disorders
6个月前
已完结
Renal Monoclonal Immunoglobulin Deposition Disease
6个月前
已完结
皖公网安备34019202002308
